W1M Asset Management Ltd bought a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 10,993 shares of the company’s stock, valued at approximately $1,412,000.
A number of other hedge funds have also recently modified their holdings of MKGAF. Keating Financial Advisory Services Inc. purchased a new stake in shares of Merck KGaA in the 2nd quarter worth $592,000. Tocqueville Asset Management L.P. purchased a new position in Merck KGaA during the second quarter valued at $57,546,000. August Group Capital Ltd bought a new stake in Merck KGaA during the second quarter valued at about $390,000. Great Lakes Advisors LLC bought a new stake in Merck KGaA during the second quarter valued at about $183,444,000. Finally, Bell & Brown Wealth Advisors LLC purchased a new stake in Merck KGaA in the second quarter worth about $5,662,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.7%
OTCMKTS MKGAF opened at $163.21 on Friday. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96. The stock’s 50-day moving average price is $162.62 and its 200-day moving average price is $148.46.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
